MICHAEL NUGENT MAXILLOFACIAL SURGERY LIMITED

Executive Summary

Michael Nugent Maxillofacial Surgery Limited is a very recently formed micro-entity with extremely limited financial resources and no trading history. Credit provision should be approached cautiously and conditioned on further financial detail and management assurances. The company’s minimal net assets and working capital indicate a fragile financial position typical at start-up phase.

MICHAEL NUGENT MAXILLOFACIAL SURGERY LIMITED - Analysis Report

Company Number: 15169272

Analysis Date: 2025-07-20 18:08 UTC

1. Credit Opinion: CONDITIONAL APPROVAL
   Michael Nugent Maxillofacial Surgery Limited is a newly incorporated micro-entity with minimal financial history and very modest balance sheet figures. While it is currently active and compliant with filing deadlines, the company’s net current assets and net assets stand at just £2, indicating a very limited financial buffer. Given the early stage of operations and minimal reported assets, credit facilities could be considered but should be conditional on obtaining further financial information, business plan verification, and possibly personal guarantees from the directors due to the low capital base.

2. Financial Strength:
   The company’s financial strength is currently very weak. Total assets less current liabilities are only £2, reflecting negligible tangible or working capital resources. The balance sheet is typical for a start-up micro-entity with one employee and no significant fixed or current assets reported. Shareholders’ funds mirror the net assets at £2, indicating no accumulated reserves or retained earnings. This limited equity base exposes the company to high risk if operational expenses or liabilities increase.

3. Cash Flow Assessment:
   With current assets of £1,137 and current liabilities of £1,135, the working capital is minimal (£2), suggesting the company has just enough short-term resources to cover immediate obligations. No cash flow statements are available, but the micro-entity status and small asset base imply very tight liquidity. The company will likely rely heavily on director funding or early revenue to maintain operations. A detailed review of cash inflows and outflows, along with payment terms with suppliers and clients, is essential before extending credit.

4. Monitoring Points:

• Timely filing of annual accounts and confirmation statements to maintain compliance.
• Improvement in net current assets and shareholder equity as an indicator of financial resilience.
• Cash flow trends and operating profitability once trading is established.
• Any director or shareholder changes, especially as both PSCs hold significant control (25-50%).
• Potential personal guarantees or director loans that may underpin the company’s liquidity.
• Operational developments and client contracts in the specialized medical services sector.